Immunochemistry Diagnostic Devices And Equipment Market Report 2026

Immunochemistry Diagnostic Devices And Equipment Market Overview

• Immunochemistry Diagnostic Devices And Equipment market size has reached to $3.67 billion in 2025 • Expected to grow to $6.22 billion in 2030 at a compound annual growth rate (CAGR) of 10.9% • Growth Driver: Growing Demand For Personalized Medicine Driving Market Growth Due To Increased Need For Targeted Diagnostic Solutions • Market Trend: Multiplex Assays Revolutionizing The Immunochemistry Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Immunochemistry Diagnostic Devices And Equipment Market?

Immunochemistry diagnostic devices and equipment refer to medical tools used to detect and measure specific proteins, hormones, or other substances in the body by leveraging immune reactions. These devices are used for diagnosing diseases, monitoring treatment, and assessing health conditions through tests like hormone assays, cancer markers, and infectious disease detection. Immunochemistry equipment is crucial in laboratories and healthcare settings for accurate and efficient diagnostic testing. The main product types are immunochemistry analyzers, immunochemistry stainers, incubators, microscopes, centrifuges, autoclaves, and consumables. Centrifuges are machines that use centrifugal force to separate substances of different densities, removing moisture, or simulating gravitational effects. The immunochemistry analyzers are chemiluminescence immunoassay (CLIA) analyzers, immunofluorescence (IFA) analyzers, enzyme immunoassay (EIA) analyzers, radioimmunoassay (RIA) analyzers, enzyme-linked fluorescent assay (ELFA) systems, and multiplexed assay systems. The immunochemistry strainers are automated and semi-automated. The consumables are antibodies, antigens, enzymes, reagents, stains, buffers, disposables, and others. The various applications are endocrinology, oncology, cardiology, therapeutic drug development and monitoring, infectious disease testing, drug abuse testing, and others. They are used by various end-users, including hospitals and clinics, diagnostic laboratories, research labs, and institutes, biopharmaceutical and biotechnology companies, and others.

What Is The Immunochemistry Diagnostic Devices And Equipment Market Growth Forecast?

The immunochemistry diagnostic devices and equipment market size is expected to see rapid growth in the next few years. It will grow to $6.22 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to increasing demand for precision diagnostics, rising adoption of automated laboratory systems, expansion of personalized medicine applications, growing investment in advanced diagnostic technologies, increasing focus on early disease detection. Major trends in the forecast period include increasing adoption of automated immunoassay analyzers, rising demand for high-sensitivity diagnostic reagents, growing use of multiplex testing platforms, expansion of laboratory automation solutions, enhanced focus on workflow efficiency and accuracy.

Global Immunochemistry Diagnostic Devices And Equipment Market Segmentation

1) By Product Type: Immunochemistry Analyzers, Immunochemistry Stainers, Incubators, Microscopes, Centrifuges, Autoclaves, Consumables 2) By Consumables: Antibodies, Antigens, Enzymes, Reagents, Stains, Buffers, Disposables, Other Consumables 3) By Application: Endocrinology, Oncology, Cardiology, Therapeutic Drug Development And Monitoring, Infectious Disease Testing, Drugs Of Abuse Testing, Other Applications 4) By End Users: Hospitals And Clinics, Diagnostic Laboratories, Research Labs And Institutes, Biopharmaceutical And Biotechnology Companies, Other End Users Subsegments: 1) By Immunochemistry Analyzers: Chemiluminescence Immunoassay (CLIA) Analyzers, Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers, Radioimmunoassay (RIA) Analyzers, Fluorescence Immunoassay (FIA) Analyzers 2) By Immunochemistry Stainers: Automated Stainers, Manual Stainers 3) By Incubators: CO2 Incubators, Shaking Incubators, Heated Incubators 4) By Microscopes: Light Microscopes, Fluorescence Microscopes, Electron Microscopes 5) By Centrifuges: Microcentrifuges, Refrigerated Centrifuges, Ultracentrifuges 6) By Autoclaves: Tabletop Autoclaves, Vertical Autoclaves, Horizontal Autoclaves 7) By Consumables: Reagents and Kits, Test Plates, Filters and Membranes, Microplates and Accessories

What Is The Driver Of The Immunochemistry Diagnostic Devices And Equipment Market?

The growing demand for personalized medicine is expected to propel the growth of the immunochemistry diagnostic devices and equipment market. Personalized medicine is a medical approach that customizes healthcare decisions and treatment strategies based on an individual's unique genetic, genomic, and clinical characteristics, aiming to optimize patient outcomes and minimize adverse effects. The rising demand for personalized medicine is due to increasing awareness and acceptance of tailored treatments that consider individual genetic, lifestyle, and environmental factors to improve patient outcomes. Personalized medicine necessitates the development and utilization of advanced immunochemistry assays to identify specific biomarkers and guide tailored treatment strategies for individual patients. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based nonprofit organization promoting individualized treatment approaches, 20 of the 53 new therapeutic molecular entities approved by the Food and Drug Administration in 2023, along with six new gene and cell-based therapies, were classified as personalized medicines, accounting for approximately 38 percent of all new molecular entities approved in the country. Therefore, the growing demand for personalized medicine is driving the growth of the immunochemistry diagnostic devices and equipment industry going forward.

Key Players In The Global Immunochemistry Diagnostic Devices And Equipment Market

Major companies operating in the immunochemistry diagnostic devices and equipment market are Abbott Diagnostics, Roche Diagnostics, Siemens Healthcare Diagnostics, Diamond Diagnostics Inc., Dynex Technologies Inc., Grifols S.A., Hycor Biomedical LLC, Immunodiagnostic Systems, Inova Diagnostics, LabCorp, Mindray Medical International Limited, Ortho Clinical Diagnostics, Quest Diagnostics, Randox Laboratories, Sysmex Corporation, ThermoFisher Scientific Inc., Tosoh Bioscience, Danaher Corporation, Johnson & Johnson, Boditech Med Inc., Beckman Coulter Inc., Bio-Rad Laboratories, bioMérieux Clinical Diagnostics, Carolina Liquid Chemistries Corporate, DiaSorin Inc., Agilent Technologies Inc., Merck KGAA, Eagle Biosciences Inc., Biocare Medical LLC, Elabscience Biotechnology Inc., Bio-Genex Laboratories Inc., Diagnostic Biosystem, Histo-Line Laboratories, Rockland Immunochemicals Inc., Abcam plc, Becton Dickinson & Company, Cell Signaling Technology Inc., ImmunoChemistry Technologies LLC, Genemed Biotechnologies Inc., Miltenyi Biotec GmbH, PerkinElmer Inc., Takara Bio. Inc, Immucor Inc., Quidel Corporation

Global Immunochemistry Diagnostic Devices And Equipment Market Trends and Insights

Major companies operating in the immunochemistry market are developing new products such as multiplex assays to gain a competitive edge in the market. Multiplex assays refer to laboratory techniques that enable the simultaneous measurement and analysis of multiple analytes within a single biological sample, providing a comprehensive and efficient approach to studying multiple factors or biomarkers in a single experiment. For instance, in June 2023, Navigate BioPharma Services, Inc., a US-based biotechnology company launched new multiplex digital PCR assays designed for precise quantification of chimeric antigen receptor (CAR) T cells, a breakthrough cancer immunotherapy. These assays, based on the Qiagen QIAcuity digital PCR System, offer simultaneous measurement of CAR-T cell number, function, and persistence in clinical blood and bone marrow samples without the need for standard curves, detecting CAR-T cells at levels as low as 0.01%. This innovative assay aids clinicians in monitoring responses and safety during clinical trials, facilitating the advancement of CAR-T therapies with its sensitivity, specificity, and efficiency.

What Are Latest Mergers And Acquisitions In The Immunochemistry Diagnostic Devices And Equipment Market?

In January 2025, bioMérieux, a France-basedin vitro diagnostics company, acquired SpinChip Diagnostics ASA, for approximately $159.87 million. The purpose of this acquisition is to strengthen bioMérieux’s point-of-care diagnostics capabilities by integrating SpinChip’s rapid, high-sensitivity immunoassay platform, which can deliver results from a whole blood sample in about 10 minutes. SpinChip Diagnostics ASA is a Norwey-based company with a strong track record in developing point-of-care immunoassays for cardiac biomarkers.

Regional Outlook

North America was the largest region in the global immunochemistry diagnostic devices and equipment market in 2025. Asia-Pacific was the second-largest region in the immunochemistry diagnostic devices and equipment market. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

What Defines the Immunochemistry Diagnostic Devices And Equipment Market?

The immunochemistry diagnostic devices and equipment market consists of sales of chemiluminescence immunoassay (CLIA) analyzers, immunofluorescence (IFA) analyzers, enzyme immunoassay (EIA) analyzers, radioimmunoassay (RIA) analyzers, enzyme-linked fluorescent assay (ELFA) systems, and multiplexed assay systems that are used in immunochemistry diagnostics. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.